Cargando…
Hyperbaric oxygen treatment is associated with a decrease in cytokine levels in patients with necrotizing soft‐tissue infection
BACKGROUND: The pathophysiological understanding of the inflammatory response in necrotizing soft‐tissue infection (NSTI) and its impact on clinical progression and outcomes are not resolved. Hyperbaric oxygen (HBO(2)) treatment serves as an adjunctive treatment; however, its immunomodulatory effect...
Autores principales: | Hedetoft, Morten, Garred, Peter, Madsen, Martin Bruun, Hyldegaard, Ole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957267/ https://www.ncbi.nlm.nih.gov/pubmed/33719215 http://dx.doi.org/10.14814/phy2.14757 |
Ejemplares similares
-
Hyperbaric oxygen treatment in the management of necrotising soft-tissue infections: results from a Danish nationwide registry study
por: Hedetoft, Morten, et al.
Publicado: (2023) -
Hyperbaric oxygen treatment impacts oxidative stress markers in patients with necrotizing soft-tissue infection
por: Hedetoft, Morten, et al.
Publicado: (2021) -
Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue Infection
por: Hedetoft, Morten, et al.
Publicado: (2021) -
Key pathways and genes that are altered during treatment with hyperbaric oxygen in patients with sepsis due to necrotizing soft tissue infection (HBOmic study)
por: Vinkel, Julie, et al.
Publicado: (2023) -
Associations between YKL-40 and markers of disease severity and death in patients with necrotizing soft-tissue infection
por: Hedetoft, Morten, et al.
Publicado: (2021)